CRISPR

CRISPR1-gpr17

ID

ZDB-CRISPR-231208-11

Name

CRISPR1-gpr17

Previous Names

None

Target

gpr17 (1)

Sequence

5' - CAGGCCAGAAAGTACAAACTGG - 3'

Disclaimer

Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.

Note

The PAM site was "TGG" at the 3' end.

Genome Resources

None

Target Location

Constructs

No data available

Genomic Features

Genomic Feature	Affected Genomic Regions
bn1	gpr17

Expression

Gene expression in Wild Types + CRISPR1-gpr17

No data available

Phenotype

Phenotype resulting from CRISPR1-gpr17

No data available

Phenotype of all Fish created by or utilizing CRISPR1-gpr17

Phenotype	Fish	Conditions	Figures
spinal cord oligodendrocyte decreased amount, abnormal	gpr17^bn1/bn1; ue1Tg	standard conditions	Fig. 3 from Häberlein et al., 2022
spinal cord glial cell migration process quality, abnormal	gpr17^bn1/bn1; ue1Tg	standard conditions	Fig. 3 from Häberlein et al., 2022
oligodendrocyte EGFP expression increased amount, abnormal	gpr17^bn1/bn1; ue1Tg	standard conditions	Fig. 2 from Häberlein et al., 2022
oligodendrocyte differentiation duration, abnormal	gpr17^bn1/bn1; ue1Tg	standard conditions	Fig. 2 from Häberlein et al., 2022
oligodendrocyte cell migration process quality, abnormal	gpr17^bn1/bn1; ue1Tg	standard conditions	Fig. 3 from Häberlein et al., 2022
spinal cord EGFP expression increased amount, abnormal	gpr17^bn1/bn1; ue1Tg	standard conditions	Fig. 2 from Häberlein et al., 2022
spinal cord glial cell migration process quality, abnormal	gpr17^bn1/bn1; ue101Tg; ue102Tg	standard conditions	Fig. 3 from Häberlein et al., 2022
spinal cord oligodendrocyte decreased amount, abnormal	gpr17^bn1/bn1; ue101Tg; ue102Tg	standard conditions	Fig. 3 from Häberlein et al., 2022
oligodendrocyte cell migration process quality, abnormal	gpr17^bn1/bn1; ue101Tg; ue102Tg	standard conditions	Fig. 3 from Häberlein et al., 2022
spinal cord glial cell migration process quality, abnormal	gpr17^bn1/bn1; vu12Tg	standard conditions	Fig. 3 from Häberlein et al., 2022
spinal cord oligodendrocyte decreased amount, abnormal	gpr17^bn1/bn1; vu12Tg	standard conditions	Fig. 3 from Häberlein et al., 2022
oligodendrocyte cell migration process quality, abnormal	gpr17^bn1/bn1; vu12Tg	standard conditions	Fig. 3 from Häberlein et al., 2022
oligodendrocyte EGFP expression increased amount, abnormal	gpr17^bn1/bn1; vu17Tg	standard conditions	Fig. 2 from Häberlein et al., 2022
spinal cord EGFP expression increased amount, abnormal	gpr17^bn1/bn1; vu17Tg	standard conditions	Fig. 2 from Häberlein et al., 2022

Citations